Navigation Links
DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium
Date:3/25/2009

Thirteen Abstracts Will Be Featured at Annual Kidney Care Meeting

EL SEGUNDO, Calif., March 25 /PRNewswire/ -- DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney failure and disease (CKD), in conjunction with DaVita Clinical Research(R), today announced that company representatives will present thirteen abstracts at the National Kidney Foundation's 2009 Spring Clinical Meetings scheduled for March 25-29, 2009 in Nashville, TN. The meeting is a platform for the nation's leading renal health care providers to learn about new developments in the field of nephrology and CKD care.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

Allen R. Nissenson MD, Chief Medical Officer at DaVita says, "DaVita is continuing to lead the renal community in generating important new knowledge to improve the outcomes for patients with kidney disease. This commitment to high quality clinical research is clearly evident in the thirteen abstracts being presented at the National Kidney Foundation meeting this year."

DaVita's top ten clinical initiatives for 2009 include: striving for reduction of first-year mortality rates and reducing catheter use. At this year's National Kidney Foundation Clinical Meeting, DaVita will focus on several key research initiatives in the areas of CKD, new incident dialysis patients, and integrated pharmacy management. Highlights from these scheduled presentations will include:

  • Improved Results in CKD Management: Recent data reveals superior outcomes in the areas of CKD and mortality, anemia, incident patient management and phosphorus and coronary artery calcification. DaVita researchers note a nearly 50 percent drop in one-year mortality in Detroit area, DaVita-managed CKD clinics compared to Renal Netwo
    '/>"/>

SOURCE DaVita Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. DaVita Clinical Research Completes Record Number of Renal Trials in 2007
2. DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education
3. DaVita Abstracts Highlight Latest Research Developments at Annual Dialysis Conference
4. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
5. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
6. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
7. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
8. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
9. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
10. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
11. The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... , SALT LAKE CITY, Nov. 27 /PRNewswire-Firs...al Systems, Inc. (NYSE: VAR ), a premier supplie...ctors, will exhibit its full range of detectors at...ember 29 - December 3, 2009. Varian will also be ...lities as well as specialized cancer treatment tec...
(Date:11/26/2009)... , JOHANNESBURG, South Africa, Nov. 26 /PR...frica Company of the Year Award in the Generic Pha...uth Africa Limited. ,, (Logo: http://www.newsc...e Company of the Year Award, the following criteri...e against key competitors: growth strategy and imp...
(Date:11/25/2009)... , LOVELAND, Colo., Nov. 25 /PRNewswire-Fir... leading provider of advanced diagnostic and spe...ced today agreements with Roche Diagnostics Corpor...iliated consumables for the veterinary market. .../20000622/HESKALOGO ) ,, "Heska and Roche share...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Texas Doctor Files Case Pro Se in U S Supreme Court Against Insurance Giant on Integrity and Unethical Practices 58242 1Texas Doctor Files Case Pro Se in U S Supreme Court Against Insurance Giant on Integrity and Unethical Practices 58242 2Texas Doctor Files Case Pro Se in U S Supreme Court Against Insurance Giant on Integrity and Unethical Practices 58242 3New Cardiovascular Biomarker Available for Scientist in North America 5054 1New Cardiovascular Biomarker Available for Scientist in North America 5054 230th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 130th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 230th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 330th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 4
...Achieves Primary Endpoint Among High-Risk Infants ...n of Medically Attended,Outpatient RSV- Related Lo...7 /PRNewswire-FirstCall/ -- MedImmune, Inc.,today ...e trial,conducted for prevention of respiratory sy...b, the investigational monoclonal antibody,(MAb) a...
...D--(BUSINESS WIRE)--May 10, 2007 - An evaluation o...trogen therapy for the,treatment of vaginal atroph...as just been released by The North American,Menopa...ginal,estrogen for treatment of vaginal atrophy in...The North American Menopause Society,",the documen...
Other Medicine Technology:MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 2MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 3MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 4MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 5MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 6MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 7New Position Statement from The North American Menopause Society,Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in,Postmenopausal Women 2New Position Statement from The North American Menopause Society,Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in,Postmenopausal Women 3
(Date:11/28/2009)...eved to affect circadian rhythm, , ,... suggests that an internal body clock that goes on... bipolar disorder in children. , The finding r...of 152 children with bipolar disorder, which can m...40 children without the disorder. They linked vari...
(Date:11/27/2009)...v. 27 GSI Group Inc. (Pi...ecision technology products and semiconductor syst... Company,s shareholders has been scheduled for Fri... meeting will be announced in due course. As prev...on notice from Stephen Bershad, a holder of greate...
(Date:11/27/2009)...ch firm Replikins Ltd. today issued its latest bio... It shows that the lethality of the virus has drop...us,s current outbreak in the spring of 2009 to res...1). The H1N1 infectivity count, however, remains i...) November 27, 2009 -- Biotech firm Replikins Ltd....
(Date:11/27/2009)...27 The Gymboree Corporat... CFO/COO, will present at the NASDAQ OMX 23rd Inve...otel in London, England, on Wednesday, December 2,...e broadcast of The Gymboree Corporation,s presenta...ree.com, click on "Our Company" at the bottom of t...
(Date:11/27/2009)..., France, Nov. 27 Team Garmin-Slip...am dedicated to ethical sporting and developing th...today that it will become Team Garmin-Transitions ...sponsor of the team. Transitions Optical is the wo...fering the most advanced photochromic technology i...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3
...t to interferon beta treatments , WEDNESDAY, Jan. ...xplain why some multiple sclerosis (MS) patients r...n international study. , Starting with 206 souther... reduced by interferon beta therapy to the DNA of ...
... Center New Orleans has been selected as the inaug...William J. Gies Award for Outstanding Innovation. ...tion at a black-tie celebration on March 29, 2008 .... Gies, a pioneer in dental education, the William...
...ements in key genes connected to the p53 regulator...y creating additional safeguards in human genes to...amage that could cause cancer or a variety of gene...l Academy of Sciences. Because genetically engine...
...hicago are still being exposed to chemicals banned.... The chemicals do not appear to be affecting the ...gs appear in the current issue of the Journal of G...e Illinois Natural History Survey, said that chemi...
... by Reverend Carlton W. Veazey, President and CEO ...:, "On the 35th anniversary of Roe v. Wade, our c...t that abortion will be safe, legal, and available...g promoted in at least 17 states are sounding the ...
...l Costs, WILMINGTON, Del., Jan. 16 Bollig & Kemp...pean auto industry, has signed,a license agreement...logy,that enables auto manufacturers to realize su...acture and sell water-based basecoats for use in t...
Other Medicine News:Health News:DNA Analysis Could Help Customize Treatments for MS 2Health News:LSUHSC dental school to be awarded top national honor 2Health News:Evolution of human genome's 'guardian' gives people unique protections from DNA damage 2Health News:Evolution of human genome's 'guardian' gives people unique protections from DNA damage 3Health News:Evolution of human genome's 'guardian' gives people unique protections from DNA damage 4Health News:Herons persist in Chicago wetlands despite exposure to banned chemicals 2Health News:Herons persist in Chicago wetlands despite exposure to banned chemicals 3Health News:Statement of the Reverend Carlton W. Veazey, President and CEO of the Religious Coalition for Reproductive Choice, on the 35th Anniversary of Roe v. Wade 2Health News:DuPont Licenses Breakthrough Automotive Coating Technology to German Paint Maker 2
Malis Needle Holders
Vascular Clamps RD-S
Vascular Clamps B-1
Micro Emulsifying Needles
Medicine Products: